The powerful pre‐treatment effect: placebo responses in restless legs syndrome trials

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|19|10|1305-1310

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.19, Iss.10, 2012-10, pp. : 1305-1310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Rotigotine Transdermal Patch for the Treatment of Restless Legs Syndrome

By  

Integrative Medicine International, Vol. 1, Iss. 1, 2014-05 ,pp. : 32-43

Karger

Access to resources Recommend Favorite

Cost-effectiveness of licensed treatment options for restless legs syndrome in the UK and Sweden

By Lees M.   Roberts G.   Tabberer M.   DasGupta R.   Finnern H. W.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2919-2930

Informa Healthcare

Access to resources Recommend Favorite

Quality of Life in Restless Legs Syndrome: A Systematic Review of Clinical Trials and a Critical Review of Instruments

By Speight Jane   Howarth Ana  

The Patient: Patient-Centered Outcomes Research, Vol. 3, Iss. 3, 2010-09 ,pp. : 185-203

Adis International

Access to resources Recommend Favorite

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study

By Inoue Yuichi   Hirata Koichi   Uchimura Naohisa   Kuroda Kenji   Hattori Nobutaka   Takeuchi Masahiro  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 13-21

Informa Healthcare

Access to resources Recommend Favorite

Risk Factors for Restless Legs Syndrome in Dialysis Patients

By  

Nephron Clin Pract, Vol. 101, Iss. 3, 2005-07 ,pp. : c155-c160

Karger

Access to resources Recommend Favorite